Determination of Absolute Purities of Hygroscopic Substances by Quantitative NMR Analysis for the Standardization of Quantitative Reagents in the Japanese Pharmacopoeia (Part 2)-Reference-Cited by-同舟云学术

Determination of Absolute Purities of Hygroscopic Substances by Quantitative NMR Analysis for the Standardization of Quantitative Reagents in the Japanese Pharmacopoeia (Part 2)

Published:2021-01-01 Issue:1 Volume:69 Page:26-31
ISSN:0009-2363
Container-title:Chemical and Pharmaceutical Bulletin
language:en
Short-container-title:CHEMICAL & PHARMACEUTICAL BULLETIN

Author:

Uchiyama Nahoko¹,Hosoe Junko¹,Miura Toru²,Sugimoto Naoki¹,Ishizuki Kyoko¹,Yamada Yuko²,Iwamoto Yoshiaki²,Suematsu Takako³,Komatsu Takanori³,Maruyama Takeshi⁴,Igarashi Yasushi⁴,Higano Taro⁵,Shimada Norimoto⁶,Goda Yukihiro¹

Affiliation:

1. National Institute of Health Sciences

2. FUJIFILM Wako Pure Chemical Corporation

3. JEOL RESONANCE Inc.

4. Tsumura & Co.

5. Taisho Pharmaceutical Co., Ltd.

6. Tokiwa Phytochemical Co., Ltd.

Publisher

Pharmaceutical Society of Japan

Subject

Drug Discovery,General Chemistry,General Medicine

Link

https://www.jstage.jst.go.jp/article/cpb/69/1/69_c20-00296/_pdf

Reference15 articles.

1. 1) The Ministry of Health, Labour and Welfare, Japan. “The Japanese Pharmacopoeia Seventeen Edition (2016).”:‹https://www.mhlw.go.jp/file/06-Seisakujouhou-11120000-Iyakushokuhinkyoku/JP17_REV_1.pdf›, cited 10 March, 2020.

2. 2) The Ministry of Health, Labour and Welfare, Japan. “Supplement I to The Japanese Pharmacopoeia Seventeen Edition (2017).”: ‹https://www.mhlw.go.jp/content/11120000/000352508.pdf›, cited 10 March, 2020.

3. 3) The Ministry of Health, Labour and Welfare, Japan. “Supplement II to The Japanese Pharmacopoeia Seventeen Edition (2019).”: ‹https://www.mhlw.go.jp/content/11120000/000597173.pdf›, cited 10 March, 2020.

4. 4) The Ministry of Health, Labour and Welfare, Japan. “The Japanese Pharmacopoeia Seventeen Edition (2016), General Information, Quantitative Analytical Technique Utilizing Nuclear Magnetic Resonance (NMR) Spectroscopy and Its Application to Reagents in the Japanese Pharmacopoeia.”:‹https://www.pmda.go.jp/files/000217666.pdf›, cited 10 March, 2020.

5. 5) Pharmaceuticals and Medical Devices Agency (PMDA), “JP drafts for public comments. Byakkokaninjinto Extract (3 June, 2019).”: ‹https://www.pmda.go.jp/files/000229715.pdf›, ‹https://www.pmda.go.jp/files/000229752.pdf (English)›, ‹https://www.pmda.go.jp/rs-std-jp/standards-development/jp/pub-comments/jp/0161.html›, ‹https://www.pmda.go.jp/english/rs-sb-std/standards-development/jp/pub-comments/jp/0013.html (English)›, cited 10 March, 2020. A request for comments on the original draft of the Japanese Pharmacopoeia (June 2019, part 2).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Absolute purity determination of an organic fluorine pharmaceutical voriconazole via quantitative 19F NMR and method validation;Journal of Pharmaceutical and Biomedical Analysis Open;2024-12

2. Quantitative <sup>31</sup>P-NMR for Purity Determination of Organophosphorus Compounds (Pharmaceuticals);YAKUGAKU ZASSHI;2024-04-01

3. Route to the Adoption of Quantitative NMR in the Japanese Pharmacopoeia;YAKUGAKU ZASSHI;2024-04-01

4. Quantitative NMR in Quality Control;Quality Control of Chinese Medicines;2024

5. Quantitative <sup>31</sup>P-NMR for the Purity Determination of the Organophosphorus Compound Brigatinib and Its Method Validation;Chemical and Pharmaceutical Bulletin;2024-01-01